Table 3.
Differences in outcome measures from baseline (T0) to the end of 4-week rehabilitation treatment (T1) and the follow-up assessment at 3 months from the baseline (T2).
| T0 | T1 | T0-T1 P-value | T2 | T0-T2 P-value | |
|---|---|---|---|---|---|
| BFI | 5.4 ± 1.6 | 4.2 ± 1.7 | 0.004 | 4.4 ± 1.6 | 0.004 |
| FFM (kg) | 43.2 ± 6.4 | 44.4 ± 6.2 | 0.231 | 45.5 ± 6.6 | <0.001 |
| FM (kg) | 24.0 ± 10.6 | 22.9 ± 10.2 | 0.297 | 21.7 ± 10.0 | <0.001 |
| HGS (kg) | 20.1 ± 5.8 | 22.5 ± 5.2 | <0.001 | 21.7 ± 6.0 | 0.012 |
| SPPB | 9.3 ± 2.0 | 11.3 ± 1.2 | <0.001 | 11.7 ± 0.5 | <0.001 |
| 10 MWT (m/s) | 1.5 ± 0.3 | 1.8 ± 0.3 | <0.001 | 1.9 ± 0.3 | <0.001 |
| 6 MWT (m) | 464.5 ± 62.9 | 554.1 ± 71.6 | <0.001 | 567.1 ± 82.7 | <0.001 |
| EORTC QLQ-C30 | |||||
| Functional score | 69.2 ± 14.9 | 76.9 ± 15.7 | <0.001 | 75.0 ± 17.1 | 0.005 |
| Symptoms score | 29.2 ± 14.9 | 21.2 ± 16.0 | <0.001 | 21.9 ± 18.5 | <0.001 |
| Global Health score | 40.7 ± 12.5 | 67.6 ± 14.8 | <0.001 | 65.2 ± 20.0 | <0.001 |
BFI, Brief Fatigue Inventory; FFM, fat-free mass; FM, fat mass; HGS, hand-grip strength test; SPPB, Short Physical Performance Battery; 10 MWT, 10-min walking test; 6 MWT, 6-min walking test; EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire.